Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer.
Appears in 4 contracts
Sources: Contingent Value Rights Agreement (Neurogen Corp), Contingent Value Rights Agreement (Ligand Pharmaceuticals Inc), Contingent Value Rights Agreement (Ligand Pharmaceuticals Inc)
Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer. Any attempted sale, assignment, transfer, pledge, encumbrance, transfer or disposition, in whole or in part, that is not a Permitted Transfer will be void ab initio and of no effect.
Appears in 4 contracts
Sources: Contingent Value Rights Agreement (Carisma Therapeutics Inc.), Agreement and Plan of Merger and Reorganization (Sesen Bio, Inc.), Contingent Value Rights Agreement (Sesen Bio, Inc.)
Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through pursuant to a Permitted Transfer.
Appears in 4 contracts
Sources: Contingent Value Rights Agreement (Actavis PLC), Contingent Value Rights Agreement (Forest Laboratories, LLC), Contingent Value Rights Agreement (Forest Laboratories Inc)
Nontransferable. The Aplindore CVRs are not capable of being and shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer.
Appears in 4 contracts
Sources: Contingent Value Rights Agreement (Yumanity Therapeutics, Inc.), Contingent Value Rights Agreement (Proteostasis Therapeutics, Inc.), Contingent Value Rights Agreement (Qualigen Therapeutics, Inc.)
Nontransferable. The Aplindore CVRs shall CVR may not be sold, assigned, transferredTransferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted Transfer.
Appears in 2 contracts
Sources: Contingent Value Rights Agreement (Paratek Pharmaceuticals, Inc.), Contingent Value Rights Agreement (Radius Health, Inc.)
Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted TransferTransfer or in connection with pledges in connection with bona fide margin accounts or other loan or financing agreement secured by the CVRs.
Appears in 2 contracts
Sources: Contingent Value Rights Agreement (EPIX Pharmaceuticals, Inc.), Contingent Value Rights Agreement (EPIX Pharmaceuticals, Inc.)
Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through pursuant to a Permitted TransferAssignment.
Appears in 1 contract
Sources: Contingent Value Rights Agreement (Centessa Pharmaceuticals LTD)
Nontransferable. The Aplindore CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, of either in whole or in part, other than through a Permitted Transfer.
Appears in 1 contract
Sources: Contingent Value Rights Agreement (DARA BioSciences, Inc.)
Nontransferable. The Aplindore CVRs are not capable of being and shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than through a Permitted TransferTransfer or with the advance written consent of Parent.
Appears in 1 contract
Sources: Contingent Value Rights Agreement (Ligand Pharmaceuticals Inc)